Abstract
02Mar 2018 CLINICAL AND BIOCHEMICAL STUDY OF FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE. Mohamed A. Alsenbesy , Abdel-Kader A. Hashim , Abdallah E. Mohamed and Mohammed H. Hassan. Department of Internal Medicine- Faculty of Medicine- South Valley University, Qena-Egypt. Department of Clinical Pathology- Faculty of Medicine- South Valley University, Qena-Egypt. Department of Medical Biochemistry-Faculty of Medicine- South Valley University, Qena-Egypt.
Highlights
Factor23 (FGF23) and secondary hyperparathyroidism to changes in minerals and bone metabolism among chronic kidney disease (CKD) patients is a challenge
The present study aimed to evaluate the role of FGF23 in CKD of various grades and potential utility for early
Colorimetric assays of serum urea, creatinine, phosphorous and calcium, while, ELISA assays of parathormone hormone (PTH) and FGF23, were done to all included patients
Summary
CLINICAL AND BIOCHEMICAL STUDY OF FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE. Mohamed[2] and Mohammed H. 1. Department of Internal Medicine- Faculty of Medicine- South Valley University, Qena-Egypt. 2. Department of Clinical Pathology- Faculty of Medicine- South Valley University, Qena-Egypt. 3. Department of Medical Biochemistry-Faculty of Medicine- South Valley University, Qena-Egypt
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
